BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27573701)

  • 21. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.
    Chen D; Wu X; Xia M; Wu F; Ding J; Jiao Y; Zhan Q; An F
    Oncol Rep; 2017 Oct; 38(4):2182-2188. PubMed ID: 28849236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary microRNAs in oral cancer.
    Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
    Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer.
    Ariston Gabriel AN; Wang F; Jiao Q; Yvette U; Yang X; Al-Ameri SA; Du L; Wang YS; Wang C
    Mol Cancer; 2020 Aug; 19(1):132. PubMed ID: 32854710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5'‑isomiR is the most abundant sequence of miR‑1246, a candidate biomarker of lung cancer, in serum.
    Aiso T; Ueda M
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36960865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer.
    Shimura T; Shibata M; Gonda K; Kofunato Y; Okada R; Ishigame T; Kimura T; Kenjo A; Kono K; Marubashi S
    Anticancer Res; 2017 Sep; 37(9):4979-4986. PubMed ID: 28870921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of selective exosomal microRNA expression profile derived from laryngeal squamous cell carcinoma detected by next generation sequencing.
    Huang Q; Yang J; Zheng J; Hsueh C; Guo Y; Zhou L
    Oncol Rep; 2018 Nov; 40(5):2584-2594. PubMed ID: 30226543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms.
    Matse JH; Yoshizawa J; Wang X; Elashoff D; Bolscher JG; Veerman EC; Leemans CR; Pegtel DM; Wong DT; Bloemena E
    PLoS One; 2015; 10(11):e0142264. PubMed ID: 26544193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes: potential for early detection in pancreatic cancer.
    Lu L; Risch HA
    Future Oncol; 2016; 12(8):1081-90. PubMed ID: 26860951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA expression profiles of bovine milk exosomes in response to Staphylococcus aureus infection.
    Sun J; Aswath K; Schroeder SG; Lippolis JD; Reinhardt TA; Sonstegard TS
    BMC Genomics; 2015 Oct; 16():806. PubMed ID: 26475455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
    Du Y; Liu M; Gao J; Li Z
    Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
    Jin H; Wu Y; Tan X
    Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
    Byun JS; Hong SH; Choi JK; Jung JK; Lee HJ
    Oral Dis; 2015 Nov; 21(8):987-93. PubMed ID: 26389700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p.
    Ding G; Zhou L; Qian Y; Fu M; Chen J; Chen J; Xiang J; Wu Z; Jiang G; Cao L
    Oncotarget; 2015 Oct; 6(30):29877-88. PubMed ID: 26337469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.
    Zhang L; Farrell JJ; Zhou H; Elashoff D; Akin D; Park NH; Chia D; Wong DT
    Gastroenterology; 2010 Mar; 138(3):949-57.e1-7. PubMed ID: 19931263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.